• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ESG
Click for more information
1.17% $3.72

Smartshares Global Equities ESG ETF Units

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ESG
Ann: ESG NTA 19-09-2024 $3.67954 		20/09/24 0 47
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  47 
ESG
Ann: Name Change - Smartshares Exchange Traded Funds 		20/09/24 0 22
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  22 
ESG
Ann: ESG NTA 18-09-2024 $3.68816 		19/09/24 0 35
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  35 
ESG
Ann: ESG NTA 17-09-2024 $3.68488 		18/09/24 0 38
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  38 
ESG
Ann: ESG NTA 16-09-2024 $3.68729 		17/09/24 0 38
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  38 
ESG
Ann: ESG NTA 13-09-2024 $3.67497 		16/09/24 0 32
16/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  32 
ESG
Ann: ESG NTA 12-09-2024 $3.65273 		13/09/24 0 52
13/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  52 
ESG
Ann: ESG NTA 11-09-2024 $3.58667 		12/09/24 0 50
12/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  50 

See All Discussions arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
$3.72 		Change
0.043(1.17%) 		Mkt cap ! n/a
Open High Low Value Volume
$3.69 $3.72 $3.69 $65.05K 17.52K

Buyers (Bids)

No. Vol. Price($)
0 342 $3.66
 

Sellers (Offers)

Price($) Vol. No.
$3.75 2285 0
Last trade - 12.59pm 20/09/2024 (20 minute delay) ?
ESG (NZSX) Chart

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.